EMS-Chemie stock slips as investors take profits after recent gains

Published on 09/18/2026 at 18:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EMS-Chemie stock trades lower on September 18, 2026, with the share around CHF 802.50 on SIX and modest losses versus the prior close. Recent half-year 2026 figures showed higher sales and earnings, giving investors a mixed picture of growth and valuation.

Chemiewerk in den Alpen, symbolisch für EMS-Chemie Holding AG — Fotorealistische Ansicht einer Chemieanlage symbolisiert EMS-Chemie Holding AG mit ISIN CH0016440353 in Alpenlandschaft, Illustration mit AI erstellt.

EMS-Chemie Holding AG stock (ISIN CH0016440353) is trading lower on September 18, 2026, with investors taking profits after a strong run, as the share was quoted at around CHF 802.50 on SIX Swiss Exchange and down 0.9 percent versus the prior close in intraday trading that day.

Share price softens after recent strength

On September 18, 2026, EMS-Chemie stock was reported at CHF 802.50 in trading on SIX Swiss Exchange, corresponding to an intraday loss of 0.9 percent compared with the previous day’s close, according to price data from a Swiss stock portal.

Earlier the same day, the share was seen at CHF 803.00 on SIX, also about 0.9 percent below the prior close, underlining that the stock spent the morning session under moderate pressure as investors locked in gains following its earlier advance.

Recent half-year figures frame the valuation

For investors, the current price movement sits against the backdrop of EMS-Chemie’s most recent half-year 2026 results, which showed that the specialty chemicals group continued to grow sales and earnings in its core business segments in the first six months of 2026, according to company information published in July 2026 on its investor relations pages and summarized by financial portals.

In the half-year 2026 period, EMS-Chemie reported higher revenue compared with the same period a year earlier, with sales increasing by a double-digit percentage rate and operating profit growing faster than revenue, reflecting margin expansion in key polymer and specialty products businesses as described in those July 2026 half-year publications.

Net income for the half-year 2026 also rose versus the prior-year period, supported by improved operating margins and disciplined cost control, which helped the company to deliver earnings growth that outpaced its topline expansion and provided room for continued investment and shareholder distributions.

Stock level and investor perspective

With EMS-Chemie stock around CHF 802.50 on September 18, 2026, and down 0.9 percent on the day, the current trading level reflects a modest pullback from recent highs but still embeds the stronger revenue and profit profile shown in the half-year 2026 figures, leaving investors to weigh the improved fundamentals against the share’s valuation.